What does CUSIP 604749101 represent in this 13F holders report?

CUSIP 604749101 is the security identifier for MIRM - Mirum Pharmaceuticals, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held MIRM - Mirum Pharmaceuticals, Inc. - Common Stock in Q2 2023?

143 institutional investors reported MIRM - Mirum Pharmaceuticals, Inc. - Common Stock for Q2 2023. Use the holders table for investor-level position and value details.

Mirum Pharmaceuticals, Inc. - Common Stock (MIRM)

CUSIP: 604749101

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock
Shares outstanding: 51,400,915
Total 13F shares: 36,937,639
Share change: +2,268,210
Total reported value: $955,518,729
Put/Call ratio: 216%
Price per share: $25.87
Number of holders: 143
Value change: +$63,103,719
Number of buys: 95
Number of sells: 37

Quarterly Holders Quick Answers

What is CUSIP 604749101?
CUSIP 604749101 identifies MIRM - Mirum Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 604749101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of MIRM - Mirum Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
NEA Management Company, LLC	13F	Company	8.1%	4,186,243	$100,553,557	—	31 Mar 2023	13F
Frazier Life Sciences Management, L.P.	13F	Company	7.5%	3,860,107	$92,719,770	—	31 Mar 2023	13F
James E. Flynn	3/4/5	* Possible Member of 10% Group, 10%+ Owner	— class O/S missing	3,244,434	$90,958,032	—	06 Jun 2022	3/4/5
NEA Partners 16, L.P.	3/4/5	10%+ Owner	— class O/S missing	2,186,243	$61,291,541	—	13 Jun 2023	3/4/5
New Enterprise Associates 16, L.P.	3/4/5	10%+ Owner	— class O/S missing	2,186,243	$61,291,541	—	13 Jun 2023	3/4/5
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	4%	2,059,201	$49,462,008	—	31 Mar 2023	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	4%	2,032,335	$48,816,687	—	31 Mar 2023	13F
Niall O'Donnell	3/4/5	Director	— class O/S missing	1,621,118	$45,448,205	—	11 Nov 2022	3/4/5
Rock Springs Capital Management LP	13F	Company	3.5%	1,795,733	$43,133,507	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	3.3%	1,709,826	$41,070,020	—	31 Mar 2023	13F
Novo Holdings A/S	13F	Company	3.3%	1,684,193	$40,454,316	—	31 Mar 2023	13F
RiverVest Venture Management LLC	13F	Company	3.2%	1,621,118	$38,939,254	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	2.7%	1,369,345	$32,891,667	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	2.5%	1,273,827	$30,597,325	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	2.3%	1,170,425	$28,113,609	—	31 Mar 2023	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	2.3%	1,170,000	$28,103,400	—	31 Mar 2023	13F
Polar Capital Holdings Plc	13F	Company	1.8%	929,907	$22,336,366	—	31 Mar 2023	13F
AXA S.A.	13F	Company	1.7%	888,554	$21,343,067	—	31 Mar 2023	13F
PICTET ASSET MANAGEMENT SA	13F	Company	1.6%	804,129	$19,315,179	—	31 Mar 2023	13F
CADIAN CAPITAL MANAGEMENT, LP	13F	Company	1.4%	734,922	$17,652,826	—	31 Mar 2023	13F
PERCEPTIVE ADVISORS LLC	13F	Company	1.2%	601,566	$14,449,615	—	31 Mar 2023	13F
Prosight Management, LP	13F	Company	1.1%	567,826	$13,639,181	—	31 Mar 2023	13F
Point72 Asset Management, L.P.	13F	Company	1.1%	557,438	$13,389,661	—	31 Mar 2023	13F
Woodline Partners LP	13F	Company	1%	523,880	$12,583,598	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.81%	418,214	$10,045,508	—	31 Mar 2023	13F
FRANKLIN RESOURCES INC	13F	Company	0.78%	400,502	$9,620,058	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.76%	392,372	$9,424,776	—	31 Mar 2023	13F
BARCLAYS PLC	13F	Company	0.58%	299,463	$7,193,101	—	31 Mar 2023	13F
Soleus Capital Management, L.P.	13F	Company	0.47%	242,000	$5,812,840	—	31 Mar 2023	13F
Ensign Peak Advisors, Inc	13F	Company	0.44%	225,700	$5,421,314	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.42%	214,197	$5,145,012	—	31 Mar 2023	13F
SILVERCREST ASSET MANAGEMENT GROUP LLC	13F	Company	0.39%	201,380	$4,837,148	—	31 Mar 2023	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.3%	154,750	$3,717,095	—	31 Mar 2023	13F
Highlander Partners, L.P.	13F	Company	0.24%	122,980	$2,953,980	—	31 Mar 2023	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.21%	109,336	$2,626,251	—	31 Mar 2023	13F
SILVERARC CAPITAL MANAGEMENT, LLC	13F	Company	0.21%	105,939	$2,544,655	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.21%	105,863	$2,542,829	—	31 Mar 2023	13F
Lion Point Capital, LP	13F	Company	0.19%	97,000	$2,329,940	—	31 Mar 2023	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.19%	95,425	$2,292,107	—	31 Mar 2023	13F
Affinity Asset Advisors, LLC	13F	Company	0.18%	95,000	$2,281,900	—	31 Mar 2023	13F
Rafferty Asset Management, LLC	13F	Company	0.17%	86,161	$2,069,587	—	31 Mar 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.14%	71,694	$1,722,000	—	31 Mar 2023	13F
Simplify Asset Management Inc.	13F	Company	0.14%	70,000	$1,681,400	—	31 Mar 2023	13F
CITIGROUP INC	13F	Company	0.13%	69,377	$1,666,436	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.13%	68,747	$1,651,303	—	31 Mar 2023	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0.13%	67,500	$1,616,625	—	31 Mar 2023	13F
Palo Alto Investors LP	13F	Company	0.13%	64,700	$1,554,094	—	31 Mar 2023	13F
DEUTSCHE BANK AG\	13F	Company	0.12%	63,391	$1,522,652	—	31 Mar 2023	13F
Parkman Healthcare Partners LLC	13F	Company	0.12%	62,118	$1,492,074	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.12%	59,857	$1,437,765	—	31 Mar 2023	13F

Institutional Holders of Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) as of Q2 2023

As of 30 Jun 2023, Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) was held by 143 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 36,937,639 shares. The largest 10 holders included Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, NEA Management Company, LLC, BlackRock Inc., Rock Springs Capital Management LP, Novo Holdings A/S, RiverVest Venture Management LLC, VANGUARD GROUP INC, STATE STREET CORP, and CITADEL ADVISORS LLC. This page lists 144 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

114

Q2 2023 holders

143

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.